GlassScriptPhysician profile
Theodore G Brna
NPI 1477547016
$4,215.47
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,027 · 2020: $1,188.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $668.71 | 2019-2020 | |
| Pfizer INC. | $461.07 | 2019-2020 | |
| Glaxosmithkline, LLC. | $391.23 | 2019-2020 | |
| Amgen INC. | $363.96 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $317.85 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $299.10 | 2019-2020 | |
| Lilly USA, LLC | $298.37 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $284.64 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $215.25 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $149.97 | 2019-2020 | |
| Novo Nordisk INC | $145.88 | 2019-2020 | |
| Radius Health, INC. | $125.00 | 2019 | |
| Astellas Pharma US INC | $120.90 | 2019 | |
| Merck Sharp & Dohme LLC | $89.88 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $72.50 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $60.12 | 2019-2020 | |
| Eisai INC. | $29.30 | 2020 | |
| Arbor Pharmaceuticals, INC. | $26.43 | 2020 | |
| Abbvie INC. | $25.34 | 2019-2020 | |
| Daiichi Sankyo INC. | $21.90 | 2019 | |
| Supernus Pharmaceuticals, INC. | $13.07 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.97 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.03 | 2019 | |
| Ironwood Pharmaceuticals, INC | $11.00 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Theodore Brna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.